Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer withdraws sickle cell drug Oxbryta
Pfizer’s Sickle Cell Drug Candidates Not Hit by Oxbryta Pull
All data considered, the benefit of the therapy, Oxbryta, “no longer outweighs the risk,” Pfizer said in a statement Wednesday. The company, which also announced discontinuing clinical trials as it investigates the findings,
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
Pfizer pulls sickle cell treatment Oxbryta off global markets
The company said benefits no longer outweighed the risks, with data suggesting the drug might increase the risk of pain crises and "fatal events."
7h
on MSN
FDA alerts patients about Pfizer's Oxbryta withdrawal
The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of ...
GEN
1d
Pfizer Withdraws SCD Drug Oxbryta after EMA Discloses 16 Deaths in Trials
Sixteen patients dosed with
Pfizer
’s sickle cell disease drug
Oxbryta
® (voxelotor) in a pair of clinical trials have died ...
18h
Pfizer’s Stock Faces Challenges as Oxbryta Recall Impacts Drug Pipeline and Financial Projections
Pfizer (PFE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit Bansal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Counselor accused of assault
Seeks dismissal of charges
Stadiums to serve as shelters
Chinese submarine sank
Kotb leaving 'Today'
Military recruiting rebounds
RU hits Ukraine's power grid
To withdraw sickle cell drug
Boxes to distribute Narcan
On active shooter drills
Disbarred in DC
Settles defamation lawsuit
NC board removes 747K
Rose announces retirement
Urgent safety alert for 737s
50/50 ball ownership suit
Weekly jobless claims fall
More executives leave
Arrives in Luxembourg
US suicides steady, high
Targeted Black residents?
US economy grew
Capital goods orders up
WI duplicate ballot flap
ISR rejects ceasefire talks
$8B military aid for Ukraine
Jan. 6 report delayed
NIH finds misconduct
On Secret Service failures
Password-sharing crackdown
Feedback